Salesforce Inc. (NYSE:CRM) shares advanced 28.14% in the four weeks ended August 22, lifting the stock to near its 52-week low as investors positioned ahead of the company’s fiscal second-quarter earnings release scheduled for August 27. The gain follows a 13% year-over-year increase in Q1 FY2027 revenue to $11.1 billion and a 24% beat on earnings per share, driven by demand for its AI-powered Agentforce platform.
Analysts at Investing.com’s ProPicks AI strategy estimate Salesforce’s fair value at $310.64 per share, implying 48.5% upside from the closing price of $210.17 on August 21. The firm’s quantitative models, which process 15 years of financial data across more than 60,000 global stocks using over 150 fundamental inputs, identify Salesforce as one of up to 20 high-conviction picks per strategy. Since the platform’s November 2023 launch, the AI-driven strategy has compounded a 192.02% return, outperforming the S&P 500 by 110.86 percentage points.
Salesforce’s capital allocation includes a $25 billion share buyback program and a $5 billion equity stake in AI startup Anthropic. The company’s Agentforce platform has surpassed $1 billion in recurring revenue, supported by public-sector contracts including a $1.6 billion deal with the Department of Veterans Affairs and a $13.5 billion vehicle-fleet agreement with the U.S. Air Force. The U.S. Army is deploying Agentforce across 9.2 million service members, veterans, and military families.
The broader market remains near record highs, with the S&P 500 just 1.6% below its mid-August closing peak. Other August standout performers among equities tracked by the AI models include Mativ Holdings (NYSE:MATV) at +42.84%, Peabody Energy (NYSE:BTU) at +29.93%, Ramaco Resources (NASDAQGS:METC) at +29.77%, Gartner (NYSE:IT) at +29.72%, and Haemonetics (NYSE:HAE) at +27.19%.
